Fitz Gate portfolio company Verge Genomics inks $882 million AI drug discovery pact with AstraZeneca Alexion, its second partnership with a top 10 Pharma company in the last two years
Fitz Gate portfolio company Verge Genomics inks $882 million AI drug discovery pact with AstraZeneca Alexion, its second partnership with a top 10 Pharma company in the last two years